China National Medicines Corporation Ltd. EBIT for the year ending December 31, 2024: USD 366.90 M

China National Medicines Corporation Ltd. EBIT is USD 366.90 M for the year ending December 31, 2024, a -0.81% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • China National Medicines Corporation Ltd. EBIT for the year ending December 31, 2023 was USD 369.89 M, a -5.70% change year over year.
  • China National Medicines Corporation Ltd. EBIT for the year ending December 31, 2022 was USD 392.27 M, a 0.44% change year over year.
  • China National Medicines Corporation Ltd. EBIT for the year ending December 31, 2021 was USD 390.56 M, a 29.52% change year over year.
  • China National Medicines Corporation Ltd. EBIT for the year ending December 31, 2020 was USD 301.54 M, a -14.98% change year over year.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)